Biomarker may signal whether common back pain treatment will work, doctor finds

August 11, 2011 By John Sanford

A new study from researchers at the Stanford University School of Medicine has identified a unique protein complex that can be used to predict whether an epidural steroid injection will help relieve pain caused by a herniated disc in the lower spine.

Roughly a quarter of all people with have a herniated disc, and approximately 90 percent of herniated discs occur in the lower back. Steroid injections generally cost a few thousand dollars each, and patients often receive a series of three or more of them, said Gaetano Scuderi, MD, a clinical assistant professor of orthopaedic surgery who is the senior author of the study to be published in the Aug. 15 edition of Spine. The lead author, S. Raymond Golish, MD, PhD, was recently a fellow in spine surgery at Stanford.

“There’s about a 50-50 chance that the epidural steroid will work, so most people figure, ‘Hey, I have nothing to lose,’” Scuderi said. “However, there is a significant expense, not to mention the procedural risks and lost productivity.”

Scuderi cited a 2008 study showing that Americans spend $90 billion every year on treatments for lower-back , and said the findings in his new study provide the basis for a test that might someday lead to substantial savings for the health-care system.

A herniated disc is a problem with one of the small, spongy cushions that sit between the vertebrae of the spine. The hernia occurs when the inside portion of the disc ruptures and bulges out from between the vertebrae. If it’s in the lumbar, or lower spine, region, it may lead to pain, numbness and tingling in the legs and buttocks, not to mention a backache.

Most people with herniated discs get better within one to six months, but the symptoms can be hard to live with, so physicians often prescribe muscle relaxants, painkillers or a series of steroid injections, which have been shown to provide moderate, short-term relief. Many patients also undergo a physical-therapy regimen. In a small number of cases, surgery is needed.

But if patients with lower-back pain could be screened to determine whether they would respond to the injections, they could be spared the discomfort and cost of a futile procedure, Scuderi said, as well as its potential complications, such as bleeding, infection and thinning and even death of bone tissue.

The researchers found that when a molecular complex of fibronectin and aggrecan — protein fragments associated with degenerated or traumatized cartilage — are not present near the hernia, steroid injections almost never work. However, when the complex is present, the injections often provide significant relief. In such cases, the authors hypothesize that the interrupts the inflammatory process initiated by the fibronectin-aggrecan complex.

The study enrolled 26 patients — 19 men and seven women — over the course of a year. Of the 14 whose test samples contained the fibronectin-aggrecan complex, 12 responded to an epidural steroid injection and two did not. Of the 12 whose samples did not contain the complex, only one responded to the injection.

“We believe that the complex identified represents a bona fide and independent indicator of [epidural steroid injection]-responsive patients,” the authors write, noting that larger trials are warranted.

There are challenges to developing this finding for practical use. As it stands, testing for the is “a technically challenging clinical procedure” that is “as invasive as the injection itself,” the authors write. It requires a tube to be inserted into the outermost part of the spinal canal. Scuderi noted that the procedure also costs about as much as a single steroid injection. However, he said there may be a way to develop a cheaper, simpler sampling method — possibly by creating a blood test or using molecular imaging.

Scuderi said he and his fellow researchers also are working to determine whether the complex itself could be exploited to reduce pain. “If it’s bioactive, it may be a target for new therapies that could reduce or eliminate the pain more effectively and with fewer side effects than steroids,” he said.

Related Stories

Recommended for you

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.